Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hyperthyroidism secondary to potassium iodide |
Causative agent (attribute) |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Potassium iodide 5gr/5cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium iodide |
Inferred relationship |
Some |
|
Potassium iodide + theophylline, anhydrous 130mg/80mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium iodide |
Inferred relationship |
Some |
|
Ephedrine hydrochloride + potassium iodide 8mg/150mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium iodide |
Inferred relationship |
Some |
|
Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
4 |
Potassium iodide 65 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium iodide |
Inferred relationship |
Some |
|
Potassium iodide 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium iodide |
Inferred relationship |
Some |
|
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Ethanol- and iodine- and potassium iodide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
3 |
Product containing iodine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing ammonium bicarbonate and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing potassium iodide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Iodine- and potassium iodide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Potassium iodide 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium iodide |
Inferred relationship |
Some |
1 |
Potassium iodide 65 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Potassium iodide 65 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Product containing only ammonium bicarbonate and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing only chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
4 |
Ethanol and iodine and potassium iodide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
3 |
Iodine and potassium iodide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Potassium iodide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Product containing only potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Iodine and potassium iodide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing only potassium iodide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Potassium iodide 65 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Potassium iodide 65 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium iodide |
Inferred relationship |
Some |
1 |
Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing iodine and potassium iodide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing only iodine and potassium iodide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing precisely iodine 25 milligram/1 milliliter and potassium iodide 25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |
Product containing precisely iodine 25 milligram/1 milliliter and potassium iodide 25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium iodide |
Inferred relationship |
Some |
2 |